BKV Corp (BKV) grants 23,496 restricted stock units to legal chief

Rhea-AI Filing Summary

Larrick Lindsay B reported acquisition or exercise transactions in this Form 4 filing.

BKV Corp reported that Chief Legal and Admin Officer Lindsay B. Larrick received a grant of 23,496 restricted stock units of common stock at no cash cost. The award vests in three equal annual installments beginning on March 10, 2027. Following this grant, Larrick directly holds 153,313 shares of BKV common stock, reflecting routine equity-based compensation rather than an open-market share purchase.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larrick Lindsay B

(Last) (First) (Middle)

1200 17TH STREET, SUITE 2100

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal and Admin Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A		23,496(1)	A	$0	153,313	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Remarks:

	/s/ Kathleen Lenox, attorney-in-fact	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BKV (BKV) report for Lindsay B. Larrick?

BKV disclosed that Chief Legal and Admin Officer Lindsay B. Larrick received a grant of 23,496 restricted stock units. These units are a form of equity compensation and do not involve an open-market share purchase, aligning her interests more closely with company shareholders over time.

How many BKV shares does Lindsay B. Larrick hold after this Form 4 filing?

After the reported grant, Lindsay B. Larrick directly holds 153,313 shares of BKV common stock. This total includes the impact of the 23,496 restricted stock units awarded, which are designed to vest over multiple years according to the company’s 2024 Equity and Incentive Compensation Plan.

What is the vesting schedule for Lindsay B. Larrick’s 23,496 BKV restricted stock units?

The 23,496 restricted stock units granted to Lindsay B. Larrick vest in three equal annual installments beginning on March 10, 2027. Each vested unit entitles her to receive one share of BKV common stock, encouraging longer-term retention and alignment with the company’s long-range performance.

Did Lindsay B. Larrick buy BKV shares on the open market in this transaction?

No, this Form 4 shows a grant of 23,496 restricted stock units to Lindsay B. Larrick at a price of $0.00 per unit. The award is compensation under BKV’s 2024 Equity and Incentive Compensation Plan, not an open-market purchase of existing common shares.

What does each restricted stock unit granted by BKV to Lindsay B. Larrick represent?

Each restricted stock unit granted to Lindsay B. Larrick represents a contingent right to receive one share of BKV common stock with a par value of $0.01. Delivery of these shares depends on satisfying the vesting schedule beginning March 10, 2027, under the 2024 equity plan.